TNF-α inhibitors were introduced more than 20 years ago and are being used for an expanding number of rheumatic and autoimmune diseases, such as RA, inflammatory bowel disease (ulcerative colitis and Crohn’s disease), psoriasis, and ankylosing spondylitis. This evidence concerns the gene TNF and psoriasis.